KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Capital Employed (2021 - 2025)

Ginkgo Bioworks Holdings' Return on Capital Employed history spans 5 years, with the latest figure at 0.3% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 13.0% year-over-year to 0.3%; the TTM value through Dec 2025 reached 0.3%, up 13.0%, while the annual FY2025 figure was 0.27%, 12.0% up from the prior year.
  • Return on Capital Employed reached 0.3% in Q4 2025 per DNA's latest filing, up from 0.32% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.11% in Q3 2021 to a low of 2.03% in Q3 2022.
  • Average Return on Capital Employed over 5 years is 0.67%, with a median of 0.51% recorded in 2023.
  • Peak YoY movement for Return on Capital Employed: tumbled -192bps in 2022, then soared 157bps in 2023.
  • A 5-year view of Return on Capital Employed shows it stood at 0.93% in 2021, then decreased by -17bps to 1.09% in 2022, then skyrocketed by 53bps to 0.51% in 2023, then grew by 18bps to 0.42% in 2024, then rose by 30bps to 0.3% in 2025.
  • Per Business Quant, the three most recent readings for DNA's Return on Capital Employed are 0.3% (Q4 2025), 0.32% (Q3 2025), and 0.27% (Q2 2025).